Kbc Group Nv Innoviva, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Innoviva, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 2,357 shares of INVA stock, worth $42,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,357

Previous 2,357 -0.0%

Holding current value

$42,048

Previous $39,000 17.95%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.32 - $16.27 $29,678 - $39,194	-2,409 Reduced 50.55%	2,357 $38,000
Q3 2023 Feb 15, 2024	SELL	$12.37 - $13.89 $23,218 - $26,071	-1,877 Reduced 39.38%	2,889 $38,000
Q2 2023 Feb 15, 2024	SELL	$11.39 - $13.72 $14,818 - $17,849	-1,301 Reduced 21.44%	4,766 $61,000
Q1 2023 Feb 14, 2024	SELL	$10.73 - $13.6 $13,959 - $17,693	-1,301 Reduced 21.44%	4,766 $54,000
Q1 2023 May 04, 2023	SELL	$10.73 - $13.6 $13,959 - $17,693	-1,301 Reduced 21.44%	4,766 $54,000
Q3 2022 Feb 15, 2024	BUY	$11.61 - $15.22 $43,073 - $56,466	3,710 Added 157.4%	6,067 $70,000
Q2 2022 Feb 14, 2024	SELL	$14.32 - $19.88 $153,209 - $212,696	-10,699 Reduced 63.81%	6,067 $90,000
Q2 2022 Jul 26, 2022	SELL	$14.32 - $19.88 $153,209 - $212,696	-10,699 Reduced 63.81%	6,067 $90,000
Q4 2021 Feb 14, 2024	BUY	$15.91 - $18.72 $229,247 - $269,736	14,409 Added 611.33%	16,766 $289,000
Q4 2021 Feb 03, 2022	BUY	$15.91 - $18.72 $157,684 - $185,533	9,911 Added 144.58%	16,766 $289,000
Q1 2020 May 04, 2020	SELL	$8.11 - $15.23 $364,276 - $684,085	-44,917 Reduced 86.76%	6,855 $81,000
Q2 2019 Jul 30, 2019	SELL	$13.1 - $14.95 $810,876 - $925,390	-61,899 Reduced 54.45%	51,772 $0
Q1 2019 May 10, 2019	SELL	$13.69 - $20.06 $296,114 - $433,897	-21,630 Reduced 15.99%	113,671 $0
Q4 2018 Jan 31, 2019	SELL	$13.96 - $18.26 $604,984 - $791,333	-43,337 Reduced 24.26%	135,301 $2.36 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $730,472 - $841,410	53,593 Added 42.86%	178,638 $0
Q1 2018 May 09, 2018	BUY	$13.8 - $16.99 $618,874 - $761,933	44,846 Added 55.92%	125,045 $0
Q4 2017 Feb 07, 2018	SELL	$11.73 - $14.75 $39,612 - $49,810	-3,377 Reduced 4.04%	80,199 $0
Q3 2017 Nov 13, 2017	BUY	$12.06 - $14.12 $1.01 Million - $1.18 Million	83,576	83,576 $0

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account